These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8672021)

  • 21. [Gastrin-releasing peptide as a specific tumor marker in patients with small cell lung carcinoma, compared with neuron-specific enolase].
    Maruno K
    Nihon Geka Gakkai Zasshi; 1990 Jun; 91(6):760-5. PubMed ID: 2169019
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating resistin concentrations in children depend on renal function.
    Nüsken KD; Kratzsch J; Wienholz V; Stöhr W; Rascher W; Dötsch J
    Nephrol Dial Transplant; 2006 Jan; 21(1):107-12. PubMed ID: 16144855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The value of serum tumor marker in the diagnosis of lung cancer].
    Shi GL; Hu XL; Yue SD; Song CX
    Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):299-301. PubMed ID: 15996327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Brain natriuretic peptide (BNP) and N-terminal-pro BNP in chronic haemodialysed renal failure].
    Bertinchant JP
    Arch Mal Coeur Vaiss; 2004 Sep; 97(9):881-8. PubMed ID: 15521481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pro-gastrin-releasing peptide (proGRP) in patients with benign and malignant diseases: comparison with CEA, SCC, CYFRA 21-1 and NSE in patients with lung cancer.
    Molina R; Auge JM; Filella X; Viñolas N; Alicarte J; Domingo JM; Ballesta AM
    Anticancer Res; 2005; 25(3A):1773-8. PubMed ID: 16033098
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of progastrin-releasing peptide and gastrin-releasing peptide receptor mRNA transcripts in tumor cells of patients with small cell lung cancer.
    Uchida K; Kojima A; Morokawa N; Tanabe O; Anzai C; Kawakami M; Eto Y; Yoshimura K
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):633-40. PubMed ID: 12474049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pro gastrin-releasing peptide (ProGRP)].
    Ishikawa H; Saito T
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():759-61. PubMed ID: 16149633
    [No Abstract]   [Full Text] [Related]  

  • 28. Sensitive detection of small cell lung carcinoma cells by reverse transcriptase-polymerase chain reaction for prepro-gastrin-releasing peptide mRNA.
    Saito T; Kobayashi M; Harada R; Uemura Y; Taguchi H
    Cancer; 2003 May; 97(10):2504-11. PubMed ID: 12733150
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevation of serum pro-gastrin-releasing peptide in patients with medullary thyroid carcinoma and small cell lung carcinoma.
    Ide A; Ashizawa K; Ishikawa N; Ishii R; Ando T; Abe Y; Sera N; Usa T; Tominaga T; Ejima E; Nakashima M; Ito K; Ito K; Eguchi K
    Thyroid; 2001 Nov; 11(11):1055-61. PubMed ID: 11762716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted determination of the early stage SCLC specific biomarker pro-gastrin-releasing peptide (ProGRP) at clinical concentration levels in human serum using LC-MS.
    Winther B; Moi P; Paus E; Reubsaet JL
    J Sep Sci; 2007 Nov; 30(16):2638-46. PubMed ID: 17874417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Cyfra 21-1--a new tumor marker of the cytokeratin series in differential diagnosis of lung diseases].
    Oremek GM; Seiffert UB; Siekmeier R; Kirsten R
    Med Klin (Munich); 1995 Jan; 90(1):23-6. PubMed ID: 7533887
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum and urinary levels of insulin-like growth factor I in patients with chronic renal disease and diabetes mellitus: its clinical implication.
    Fujihara M; Uemasu J; Kawasaki H
    Clin Nephrol; 1996 Jun; 45(6):372-8. PubMed ID: 8793228
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum endostatin levels in patients with lung carcinoma.
    Swidzińska E; Ossolińska M; Naumnik W; Trojan S; Chyczewska E
    Rocz Akad Med Bialymst; 2005; 50():197-200. PubMed ID: 16358965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum pro-gastrin-releasing peptide is a useful marker for treatment monitoring and survival in small-cell lung cancer.
    Sunaga N; Tsuchiya S; Minato K; Watanabe S; Fueki N; Hoshino H; Makimoto T; Ishihara S; Saito R; Mori M
    Oncology; 1999; 57(2):143-8. PubMed ID: 10461062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
    Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Enterostatin, galanin, and GRP].
    Nagase H; Inamori M
    Nihon Rinsho; 2005 Aug; 63 Suppl 8():524-7. PubMed ID: 16149568
    [No Abstract]   [Full Text] [Related]  

  • 37. Hyperleptinemia in chronic renal failure.
    Iida M; Murakami T; Yamada M; Sei M; Kuwajima M; Mizuno A; Noma Y; Aono T; Shima K
    Horm Metab Res; 1996 Dec; 28(12):724-7. PubMed ID: 9013751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevated plasma concentrations of C-flanking gastrin-releasing peptide in small-cell lung cancer.
    Holst JJ; Hansen M; Bork E; Schwartz TW
    J Clin Oncol; 1989 Dec; 7(12):1831-8. PubMed ID: 2555450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Plasma gastrin-releasing peptide analysis and the clinical significance].
    Maruno K; Yamaguchi K; Abe K
    Nihon Rinsho; 1990 Feb; 48 Suppl():100-3. PubMed ID: 2162407
    [No Abstract]   [Full Text] [Related]  

  • 40. Pro-gastrin-releasing peptide in patients with benign and malignant diseases.
    Molina R; Auge JM; Alicarte J; Filella X; Viñolas N; Ballesta AM
    Tumour Biol; 2004; 25(1-2):56-61. PubMed ID: 15192313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.